Stock listing
NASDAQ:SAGE Sage Therapeutics Inc Stock
Follow Sage Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SAGE
$8.68 USD
Close on Jul 31, 2025 · No longer trades
- Lowest – highest close
- $4.78 – $192.33 USDSince Jul 18, 2014 · lowest Nov 18, 2024 · highest Feb 1, 2018
Delisted NASDAQ:SAGE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SAGE
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Sage Therapeutics Inc on 6ix
- Calls
- 19 calls with a replay · 19 with a transcript · latest Apr 29, 2025
- Decks
- 9 decks · latest Apr 29, 2025
Events
| Call | When | Status |
|---|---|---|
| Sage Therapeutics (SAGE) Q1 2025 Earnings Call | Tue, Apr 29, 2025 · 4:30 PM ET | Replay |
| Sage Therapeutics (SAGE) Q4 2024 Earnings Call | Tue, Feb 11, 2025 · 4:30 PM ET | Replay |
| Sage Therapeutics (SAGE) Q3 2024 Earnings Call | Tue, Oct 29, 2024 · 4:30 PM ET | Replay |
| Sage Therapeutics (SAGE) Q2 2024 Earnings Call | Wed, Jul 31, 2024 · 4:30 PM ET | Replay |
| Sage Therapeutics (SAGE) Q1 2024 Earnings Call | Thu, Apr 25, 2024 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q4 2023 Earnings Call | Wed, Feb 14, 2024 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q3 2023 Earnings Call | Tue, Nov 07, 2023 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q2 2023 Earnings Call | Mon, Aug 07, 2023 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q1 2023 Earnings Call | Tue, May 02, 2023 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q4 2022 Earnings Call | Thu, Feb 16, 2023 · 8:00 AM ET | Replay |
All 19 calls
| Call | When | Status |
|---|---|---|
| Sage Therapeutics (SAGE) Q3 2022 Earnings Call | Tue, Nov 08, 2022 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q2 2022 Earnings Call | Tue, Aug 02, 2022 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q1 2022 Earnings Call | Tue, May 03, 2022 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q4 2021 Earnings Call | Thu, Feb 24, 2022 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q3 2021 Earnings Call | Tue, Nov 02, 2021 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q2 2021 Earnings Call | Tue, Aug 03, 2021 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q1 2021 Earnings Call | Tue, May 04, 2021 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q4 2020 Earnings Call | Wed, Feb 24, 2021 · 8:00 AM ET | Replay |
| Sage Therapeutics (SAGE) Q3 2020 Earnings Call | Thu, Nov 05, 2020 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 2025 Earnings Presentation | Earnings | 9 slides | Apr 29, 2025 |
| FY2024 Earnings Presentation | Earnings | 10 slides | Feb 11, 2025 |
| J.P. Morgan Healthcare Conference January 2025 | Conference | 12 slides | Jan 13, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 10 slides | Oct 29, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 13 slides | Jul 31, 2024 |
| J.P. Morgan Healthcare Conference 2024 | Conference | 24 slides | Jan 8, 2024 |
| J.P. Morgan Healthcare Conference 2023 | Conference | 21 slides | Jan 9, 2023 |
| J.P. Morgan Healthcare Conference 2022 | Conference | 30 slides | Jan 10, 2022 |
| January 2019 J.P. Morgan Healthcare Conference | Conference | 20 slides | Jan 7, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kevin P Starr Other companies: MyoKardia Inc (Director · Oct 28, 2015 – Mar 7, 2018 · Past); Global Blood Therapeutics Inc (Director · Aug 11, 2015 – Aug 17, 2015 · Past); Larimar Therapeutics, Inc. (Director · Jun 18, 2014 – Sep 24, 2015 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Feb 19, 2015 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 1, 2007 – Jun 2, 2017 · Past); Human Genome Sciences Inc (Director · May 3, 2007 – Jul 10, 2007 · Past) | Director · Jul 17, 2014 – Jun 15, 2023 · Past |
| Steve Paul Other companies: Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); Rapport Therapeutics, Inc. (Director · Since at least Jun 6, 2024); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Mar 18, 2024 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 3, 2016 – Apr 1, 2022 · Past); Sigma-Aldrich Corp (Director · Nov 18, 2015 – Nov 18, 2015 · Past); Voyager Therapeutics, Inc. (Director · Nov 10, 2015 – Jun 3, 2021 · Past) | Director · Jul 1, 2015 – Jan 3, 2024 · Past |
| Geno Germano Other companies: Harmony Biosciences Holdings, Inc. (Director · Since at least Apr 2, 2026); Entera Bio Ltd. (Chairman of the Board · Since at least Feb 4, 2026); Precision BioSciences, Inc. (Director · Since at least Mar 10, 2020); Bioverativ Inc (Director · Jan 31, 2018 – Mar 8, 2018 · Past); The Medicines Company (Director · Nov 9, 2017 – Jan 6, 2020 · Past) | Director · Since at least Jun 6, 2018 |
| Michael Cola Other companies: Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Avalo Therapeutics, Inc. (Chief Executive Officer, Director · Feb 3, 2020 – Oct 1, 2021 · Past); Aevi Genomic Medicine LLC (Chief Executive Officer, Director · Sep 13, 2013 – Jun 9, 2020 · Past); Vanda Pharmaceuticals Inc. (Director · Jun 14, 2012 – Jun 13, 2019 · Past); NuPathe Inc. (Director · Sep 30, 2011 – Feb 21, 2014 · Past) | Director · Since at least Sep 11, 2014 |
| Jeffrey M Jonas Other companies: COMPASS Pathways Plc (Director · Since at least Oct 29, 2025); Generation Bio Co (Director · Since at least Jun 11, 2020); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Mar 15, 2024 · Past) | Director · May 23, 2019 – Jun 10, 2024 · Past |
| Anne Marie Cook Other companies: Phathom Pharmaceuticals, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Jun 23, 2025); Aegerion Pharmaceuticals Inc (SVP, General Counsel · Dec 5, 2011 – Aug 4, 2015 · Past) | SVP, GC & Secretary · Sep 16, 2015 – Aug 5, 2024 · Past |
| Michael Cloonan Other companies: Sionna Therapeutics, Inc. (President & CEO, Director · Since at least Feb 6, 2025); Bluebird bio Inc (Director · Since at least Jun 20, 2024) | Chief Business Officer · Apr 2, 2018 – Feb 10, 2021 · Past |
| Gregory L Shiferman Other companies: Voyager Therapeutics, Inc. (SVP and General Counsel · Since at least Jan 6, 2026) | See Remarks · Since at least Apr 10, 2025 |
| Albert Robichaud | Chief Scientific Officer · Feb 10, 2021 – Feb 13, 2023 · Past |
| Asha Nayak | Director · Nov 6, 2017 – Jun 5, 2019 · Past |
All 12 people
| Person | Seat |
|---|---|
| Christopher Benecchi | Chief Operating Officer · Since at least Sep 13, 2021 |
| Elizabeth Barrett | Director · Jan 22, 2019 – Jun 10, 2024 · Past |
Log in to ask 6ix AI your own questions about Sage Therapeutics Inc.